Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice

ABSTRACT

Rauwolfia serpentina is well-reported in traditional medicines for the treatment of hypertensive and neurological disorders. However, its antidiabetic potential has been currently described in both alloxan-treated and normoglycemic mice. Present effort was carried out to investigate the effect of methanol root extract [MREt] of R.serpentina in fructose-induced type 2 diabetic mice. Experimental mice were grouped into normal control [distilled water 1ml/kg] and fructose-induced type 2 diabetic groups [10% fructose 1 ml/kg].The second group sub-divided into negative [0.05% DMSO 1ml/kg] control, positive [pioglitazone 15mg/kg] control and three test groups [MREt 10, 30 and 60 mg/kg]. Each treatment was given orally for 14 days consecutively then mice were sacrificed in order to collect serum and liver samples to analyze physical, biochemical as well as hematological markers. MREt significantly improved percent body weight and glycemic change along with serum insulin, total cholesterol [TC], triglycerides [TG], lowdensity lipoprotein [LDL-c], very low-density lipoprotein [VLDL-c], high-density lipoprotein-cholesterols [HDL-c], total hemoglobin, glycosylated hemoglobin, hepatic glycogen, coronary risk and fasting insulin resistance indices while suppressed down the activity of 3-hydroxy-3-methylglutaryl Coenzyme A reductase enzyme in test groups when compared with diabetic controls. The present findings conclude that MREt of R. serpentina can effectively betters the carbohydrate and lipid homeostasis by either inhibiting fructose absorption in intestine or decreasing insulin resistance in fructose-induced type 2 diabetic mice